Showing posts with label Peter Doherty. Show all posts
Showing posts with label Peter Doherty. Show all posts

Monday, November 04, 2013

Professor Peter Doherty On Pandemics & History

image

Credit Wikipedia

 

 

# 7933

 

Laureate Professor Peter C. Doherty (who shared the 1996 Nobel Prize for medicine for his work in immunology) divides his time between St Jude Children’s Research Hospital in Memphis and the Department of Microbiology and Immunology at the University of Melbourne.

 

Professor Doherty is also an author, with several books to his credit, the latest being Pandemics: What Everyone Needs to Know (Oxford).

 

Today, a long interview (by Robin Lindley) with Professor Doherty appears on George Mason University’s History News Network, where they discuss the `enormous influence’ that pandemics have had on human history.

 

From Alexander the Great (who many believe died from malaria at the age of 32), to the devastating Black Death of Europe in the 1300s, to the Spanish Flu of 1918 – epidemics and pandemics have often dictated the course of human events. 


Follow the link below to read the interview in its entirety.

 

11-4-13

 

Peter C. Doherty: Pandemics Have Had "Enormous Influence" on History [INTERVIEW]

tags: public health, history of medicine, pandemics
by Robin Lindley

 

 

For more on Professor Doherty, you may wish to revisit the following blogs:

 
mBio: Taubenberger et al. On the 1918 Spanish Flu
Peter Doherty On H5N1 Research
Prof. Peter Doherty On Influenza’s Threat
Professor Peter Doherty On Bird Flu

Tuesday, February 21, 2012

Peter Doherty On H5N1 Research

 

image

BSL-4 Lab Worker - Photo Credit –USAMRIID

# 6161

 

 

Laureate Professor Peter C. Doherty (who shared the 1996 Nobel Prize for medicine for his work in immunology) divides his time between St Jude Children’s Research Hospital in Memphis and the Department of Microbiology and Immunology at the University of Melbourne.

 

I’ve profiled a number of Professor Doherty’s articles in the past, including:

Prof. Peter Doherty On Influenza’s Threat
Professor Peter Doherty On Bird Flu

 


Today Professor Doherty, along with Paul Thomas, PhD. (also from St. Jude Research Center) – have published an open access opinion piece in BMC Biology.

Dangerous for ferrets: lethal for humans?

Peter C Doherty and Paul G Thomas

BMC Biology 2012, 10:10 doi:10.1186/1741-7007-10-10

 

Of concern to these authors is the idea that H5N1 research should only be conducted in BSL-4 laboratories (a rule already adopted in Canada), which would greatly restrict the number of labs – and researchers – who would have access to the virus.

 

I’ve excerpted two paragraphs below, but follow the link above to read the whole piece.

 

While we need to be assured that Taubenberger, Hultin, Fouchier, Kawaoka-type experiments are only done by responsible people working in safe, well-regulated institutions, the problem is that imposing highly restrictive constraints (BSL4 security, in space suits) means that few will be bothered to investigate these pathogens. As a consequence, we will know less about them. The reality is that if scientists want to be funded, they must be productive and publish. It is always easy for a talented researcher to say: 'too hard, too cumbersome, I'll just go on with something else.' Those reviewing the H5N1 situation might ask whether that has indeed happened with the resurrected 1918 virus.

<SNIP>

What must be avoided at all costs is to initiate processes that limit the exchange of information in the influenza field. The overwhelming probability is that any 'human pandemic' H5N1 variant will come out of nature, not a laboratory. The combination of a superbly organized network, first class technology, well-established centers and dedicated professionals means that the global monitoring mechanisms for influenza are the best there can be. The Fouchier and Kawaoka studies identify mutations that these international 'flu detectives' will be watching for. The last thing the influenza surveillance community would want is for their work to become exclusive, especially if that leads to any reluctance to make newly isolated, dangerous H5N1 'field isolates' immediately available for general scrutiny.

Friday, November 11, 2011

Prof. Peter Doherty On The Challenge Of Developing A Universal Flu Shot

 

 

# 5957

 


Every few months the media barrages us with stories about the latest step forward towards the holy grail of influenza research; a one-time universal flu shot. 


One that would protect against all strains of influenza and last – if not a lifetime – many years.

 

Many of these `news’ reports are based on `forward looking statements’ or press releases by universities, research organizations, and other entities.

 

Often the media fails to mention in these reports that while progress is being made, there remain substantial obstacles to overcome, and any universal vaccine is still likely years away. 

 

After all, why complicate a perfectly good story with downer details like that?

 

In Part II of his series on the challenge of influenza, Australian Nobel Prize winning scientist Professor Peter Doherty outlines some of the approaches being used in the hunt for a universal flu jab, and some of the substantial difficulties that still lie ahead.

 

As Professor Doherty states in his article::

 

`The science of vaccine creation is complex, technical and incomplete and the road to a universal flu vaccine is long.’

 

11 November 2011, 2.33pm AEST

Search for the elusive universal flu vaccine

 

 

Yesterday, in Prof. Peter Doherty On Influenza’s Threat, we looked at Part 1 of this series.

Thursday, November 10, 2011

Prof. Peter Doherty On Influenza’s Threat

 

 

 

# 5953

 

 

Last August in Professor Peter Doherty On Bird Flu I wrote about an Australian Life Scientist Magazine  interview with world renown 1996 Nobel Prize winning scientist Professor Peter Doherty, who discussed the pandemic potential of the H5N1 avian virus.

 

Today, The Conversation – which is a combined journalistic effort by a number of Australian Universities – has the first of a two-part article by Professor Doherty on influenza.

 

Rather than try to excerpt or summarize his views, I’ll simply provide a link so you can read the entire article.

 

 

Author

Peter C. Doherty

Peter C. Doherty
Laureate Professor at University of Melbourne

10 November 2011, 2.36pm AEST

Global efforts against flu evolving in the face of continuing threat

Influenza is never off the news agenda for long. If it’s not the flu season (and it always is in one hemisphere) and the attendant calls for vaccinations, it’s news about vaccines causing problems or new ones that will imbue immunity to all variants and mutations of the virus.

 

In this first of a two-part series on influenza and the future of vaccines for it, Peter Doherty discusses how these viruses mutate and how we monitor them to create effective vaccines.

(Continue . . . )

Tomorrow’s article will look at the feasibility of developing a “universal” flu vaccine.

Tuesday, August 30, 2011

Professor Peter Doherty On Bird Flu

 

 

 

# 5794

 

 

With yesterday’s FAO announcement (see FAO Warns On Bird Flu), the H5N1 virus is suddenly back in the news cycle again.

 

Today, the Australian Life Scientist Magazine carries an interview with world renown, 1996 Nobel Prize winning scientist Professor Peter Doherty, who discusses the pandemic potential of this avian virus.

 

Although his comments range from research on GM (genetically modified) flu-resistant chickens to universal flu vaccines, the main thrust of the today’s article centers around the possibility that the H5N1 virus might one day swap genes (reassort) with the H1N1 virus and produce an easily transmitted, highly virulent flu strain.

 

First a link to the article, which is very much worth reading, then I’ll return with more.

 

Bird-swine flu hybrid could be a killer combo

The appearance of a new mutant of bird flu in Asia raises the concern that it might hybridise with swine flu creating a new pandemic threat.

  • Tim Dean (Australian Life Scientist)
  • 30 August, 2011 17:12

 

 

As we’ve discussed before, influenza viruses change, evolve, or mutate over time via two well established routes; Antigenic drift and Antigenic Shift.

 

Antigenic drift – the more common of the two - causes small, incremental changes in the virus over time.  Drift is the standard evolutionary process by which influenza viruses mutate, and often come about due to replication errors that are common with single-strand RNA viruses.

 

Shift occurs when one virus swap out chunks of their genetic code with gene segments from another virus.  This is known as reassortment. While far less common than drift, shift can produce abrupt, dramatic, and sometimes pandemic inducing changes to the virus.

 

This process has produced pandemic flu strains in the past, and while that obviously doesn’t happen often, virologists are quick to remind us:

 

Shift Happens.

 

mixing vessel

 

While reassortment can occur in many species, pigs have long been believed to be an ideal `mixing vessel’ for influenza because they possess both avian-like (SAα2,3Gal) and human-like (SAα2,6Gal) receptor cells in their respiratory tract.

 

That makes pigs susceptible to human, swine, and avian strains of flu. And while it may not happen often, they are capable of being infected by more than one flu virus at a time.

 

This is basically how the 2009 H1N1 pandemic virus evolved, although it took multiple gene swaps over a decade or longer before it finally emerged into the human population.

 

We know that reassortments do happen, but only rarely do they result in a biologically fit virus capable of causing a pandemic.

 

Most hybrid viruses are evolutionary dead-ends, are unable to compete, and die out within the host.

 

But as global pig production grows – particularly in places where biosecurity and surveillance may be lax – it creates increasing opportunities for a new, biologically `fit’  virus to emerge.

 

image

Source: FAO

 

Lest anyone doubt the ability of pigs to contract the H5N1 virus, a little over a year ago (see EID Journal: Asymptomatic H5N1 In Pigs) we saw research out of Indonesia that showed 52 pigs in 4 provinces were found to be infected with H5N1 between 2005–2007. 

 

While there is justifiable concern over a reassorted H5N1 virus, bird flu isn’t the only pandemic player down on the farm.

 

The H9 and H7 avian viruses, along with various strains of H3 and H1 influenza (and others) are all potential candidates for reassortment.

 

For more on the reassortment potential of avian, swine, and human flu viruses, you can’t do better than  Helen Branswell’s excellent Scientific American article from last December called Flu Factories, or her SciAm Podcast interview.

 

And for good measure, a sampling of a few of my earlier blogs on reassortment:

 

 
Review: Evolution & Adaptation Of The 2009 pdmH1N1 Virus
You Say You Want An Evolution?
EID Journal: Co-Infection By Influenza Strains
EID Journal: Swine Flu Reassortants In Pigs
If You’ve Seen One Triple Reassortant Swine Flu Virus . . .